The most shared of 2020: Global burden of CVD, virtual meetings amid pandemic, more

Healio and Cardiology Today have aggregated the most talked-about cardiology news on Twitter of 2020.

The most shared topics included the global burden of CVD; CV health in women; virtual meetings amid the pandemic; and more.

Global burden of CVD rising, high BP remains greatest modifiable risk factor

The global rise in CVD and mortality since 1990 may represent the real-world manifestation of the unmet need for affordable interventions, patients’ level risk factor education and health policies, researchers reported. Read more

Better understanding of coronary pathophysiology needed to improve CV outcomes in women

Obstructive CAD is not always the best predictor of CV events, especially in women, so a better characterization of coronary pathophysiology is necessary, according to a speaker. Read more

High LDL elevates CV risk in older patients; primary prevention may be appropriate

High LDL in older patients may confer increased risk for atherosclerotic CVD and MI, and therefore this population may benefit from targeted LDL-lowering therapies, according to two studies published in The Lancet. Read more

Many drug therapy options exist for NAFLD

Lipid-lowering therapies, diabetes drugs and liver-related therapies are among the medication options for patients with nonalcoholic fatty liver disease, according to a presentation at the National Lipid Association Scientific Sessions. Read more

ACC goes virtual to present cardiovascular science, education

From March 28 to 30, the American College of Cardiology will host its Scientific Session, together with the World Congress of Cardiology, in a virtual format, with late-breaking clinical trials, keynotes and other sessions available online. Read more

Tofu, isoflavones may decrease CHD risk

Eating higher quantities of tofu and isoflavones lowers the risk for CHD, especially in young women or postmenopausal women who do not use hormones, according to a study published in Circulation. Read more

Higher temperatures may increase heart disease mortality risk

In a new study, researchers reported that higher ambient temperatures as observed in Kuwait may be associated with higher CVD mortality. Read more

Myocardial injury may be key in predicting COVID-19 fatalities

New data from Wuhan, China, indicate that myocardial injury appears to be associated with death in patients with COVID-19. However, the association may not be as strong in patients with COVID-19 and underlying CVD but no evidence of myocardial injury, according to a retrospective single-center case study. Read more

Nighttime BP may be independent predictor of future CVD

Fluctuations in nighttime BP may represent a key predictor of future stroke, CAD and HF, according to a study published in Circulation. Read more

Icosapent ethyl reduces coronary revascularization by 11 months: REDUCE-IT REVASC

Icosapent ethyl demonstrated a very early coronary revascularization benefit, according to findings from REDUCE-IT REVASC. Read more